Health and Healthcare
577 Articles
A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of…
ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had…
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include…
In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in…
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 5, 2014. They include Apple, Lululemon,…
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is…
These are the top Wall Street analyst upgrades, downgrades and initiations seen on Thursday, May 15, 2014. They include Cisco…
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off…
Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large…
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…
Cadence Pharmaceuticals agreed Tuesday to be bought out by Mallinckrodt for $1.3 billion, or a more than 27% premium to…
Frank Golhen, via Wikimedia CommonsMost of the firms that we cover on Wall Street have presented their high conviction stock…
ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ:…
Jon OggEarnings season is in full swing and equities are challenging new highs almost daily. Traders and investors are looking…
ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…
Our top personal finance-related articles today. Your wallet will thank you later.